相似文献
1
Biotech drugs come of age; policymakers take notice.
Health Aff (Millwood). 2006 Sep-Oct;25(5):1202-3. doi: 10.1377/hlthaff.25.5.1202.
2
Biotech's billion dollar breakthrough.
Fortune. 2003 May 26;147(10):96-8, 100, 103.
3
Genomic sciences and the medicine of tomorrow.
Nat Biotechnol. 1996 Nov;14(11):1516-8. doi: 10.1038/nbt1196-1516.
4
The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Stud Hist Philos Biol Biomed Sci. 2006 Sep;37(3):583-601. doi: 10.1016/j.shpsc.2006.06.002. Epub 2006 Aug 23.
5
The market for follow-on biologics: how will it evolve?
Health Aff (Millwood). 2006 Sep-Oct;25(5):1291-301. doi: 10.1377/hlthaff.25.5.1291.
6
Biotech industry tries to recover from 2-year lull.
J Natl Cancer Inst. 2003 Mar 5;95(5):348-9. doi: 10.1093/jnci/95.5.348.
7
What's fueling the biotech engine?
Nat Biotechnol. 2007 Oct;25(10):1097-104. doi: 10.1038/nbt1007-1097.
8
Biotech R&D still reeling.
Nat Biotechnol. 2004 Sep;22(9):1068. doi: 10.1038/nbt0904-1068.
9
The further evolution of biotech.
Nat Rev Drug Discov. 2003 Jan;2(1):75-9. doi: 10.1038/nrd989.
10
R&D deals boom in 2004.
Nat Biotechnol. 2005 Sep;23(9):1036. doi: 10.1038/nbt0905-1036.
Zotero 插件